Grifols SA
GRFS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001438569
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
164
- −22 vs. Q1 2026
- Total value $1.01B
Superinvestors holding GRFS
0
- None of the superinvestors held GRFS at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by GRFS insiders, newest first.
No open-market purchases or sales by GRFS insiders are on file.
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in GRFS at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | 37,816,285 | $267.74M | 1.88% | +1,482,571+4.1% | Added |
| Capital World Investors | 22,911,656 | $162.21M | 0.02% | −13,334−0.1% | Reduced |
| Permian Investment Partners, LP | 19,740,679 | $139.76M | 15.86% | +386,000+2.0% | Added |
| Black Creek Investment Management Inc. | 7,682,055 | $54.39M | 3.05% | −704,397−8.4% | Reduced |
| BANK OF AMERICA CORP /DE/ | 6,550,337 | $46.38M | 0.00% | +2,222,924+51.4% | Added |